Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Medizinische Klinik (Munich, Germany : 1983)|November 2, 1999
[Clinical course, morphology and prognosis of chronic myelomonocytic leukemia]U Germing, C Strupp, G Meckenstock, et al.
Der Internist|January 19, 2010
[Myelodysplastic syndromes]C Aul, A Giagounidis, U Germing
International Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U Germing
Annals of Hematology|October 10, 2002
Evaluating the prognosis of patients with myelodysplastic syndromesC Aul, A Giagounidis, U Germing, et al.
Leukemia Research|November 15, 2000
Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsU Germing, N Gattermann, C Strupp, et al.
Leukemia & Lymphoma|March 23, 2002
Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reportsC Strupp, M Aivado, U Germing, et al.
Leukemia Research|November 15, 2000
Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literatureC Strupp, U Germing, I Trommer, et al.
Leukemia Research|June 28, 2005
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomideC Strupp, R Fenk, A Kündgen, et al.
Leukemia|February 13, 2002
Thalidomide for the treatment of patients with myelodysplastic syndromesC Strupp, U Germing, M Aivado, et al.
European Journal of Medical Research|January 20, 1999
Pseudomonas aeruginosa orbital phlegmon in a patient treated for myelodysplastic syndrome with concomitant Sjögren's syndromeA A Giagounidis, A S Giagounidis, U Germing, et al.
Pageof 13